Dyssynergia Cerebellaris Myoclonica
What is Dyssynergia Cerebellaris Myoclonica?
Dyssynergia Cerebellaris Myoclonica refers to a
collection of rare, degenerative, neurological disorders characterized by
epilepsy, cognitive impairment, myoclonus, and progressive ataxia. Symptoms
include seizures, tremor, and reduced muscle coordination. Onset of the disorder
generally occurs in early adulthood. Tremor may begin in one extremity and later
spread to involve the entire voluntary muscular system. Arms are usually more
affected than legs. Some of the cases are due to mitochondrial abnormalities.
Is there any treatment?
Treatment of Dyssynergia Cerebellaris Myoclonica is
symptomatic. Myoclonus and seizures may be treated with drugs like valproate.
What is the prognosis?
The progression of the disorder is usually 10 years or longer.
What research is being done?
The NINDS supports a broad range of research on
neurodegenerative disorders such as Dyssynergia Cerebellaris Myoclonica. The
goals of this research are to find ways to prevent, treat, and cure these kinds of disorders.
Organizations
National Institute on Deafness and Other Communication
Disorders (NIDCD)
National Institutes of Health, DHHS
31 Center Drive, MSC 2320
Bethesda, MD 20892-2320
nidcdinfo@nidcd.nih.gov
www.nidcd.nih.gov
Tel: 301.496.7243/800.241.1044 800.241.1055 (TTD/TTY)
National Ataxia Foundation (NAF)
2600 Fernbrook Lane North, Suite 119
Minneapolis, MN 55447-4752
naf@ataxia.org
www.ataxia.org
Tel: 763.553.0020
Fax: 763.553.0167
National Organization for Rare Disorders (NORD)
P.O. Box 1968
(55 Kenosia Avenue)
Danbury, CT 06813-1968
orphan@rarediseases.org
www.rarediseases.org
Tel: 203.744.0100 Voice Mail 800.999.NORD (6673)
Fax: 203.798.2291
Source: National Institutes of Health; National Institute of
Neurological Disorders and Stroke
index#6095
| 
